| # | Side effect | Count |
|---|---|---|
| 0 | PSORIASIS | 504 |
| 1 | DRUG INEFFECTIVE | 240 |
| 2 | ARTHRALGIA | 195 |
| 3 | INTENTIONAL PRODUCT USE ISSUE | 180 |
| 4 | PSORIATIC ARTHROPATHY | 177 |
| 5 | FATIGUE | 174 |
| 6 | PRODUCT DOSE OMISSION ISSUE | 145 |
| 7 | DISEASE RECURRENCE | 139 |
| 8 | THERAPY INTERRUPTED | 139 |
| 9 | HEADACHE | 131 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | PATIENT DISSATISFACTION WITH TREATMENT | 80 | 0.0415 |
| 1 | ERYTHRODERMIC PSORIASIS | 18 | 0.0218 |
| 2 | CUTANEOUS T-CELL LYMPHOMA | 14 | 0.0111 |
| 3 | PRODUCT DISTRIBUTION ISSUE | 55 | 0.0059 |
| 4 | PUSTULAR PSORIASIS | 15 | 0.0044 |
| 5 | PSORIATIC ARTHROPATHY | 177 | 0.0044 |
| 6 | PSORIASIS | 504 | 0.0039 |
| 7 | SYMPTOM RECURRENCE | 22 | 0.0037 |
| 8 | DISEASE RECURRENCE | 139 | 0.0029 |
| 9 | INTENTIONAL PRODUCT USE ISSUE | 180 | 0.0021 |